References
- Archana P, Sathishkumar N, Bharathi N. 2010. In silico docking analysis of curcumin–an inhibitor for obesity. Int J Pharm Bio Sci 1:224–235.
- Bastien M, Poirier P, Lemieux I, Després J-P. 2014. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis. 56:369–381.10.1016/j.pcad.2013.10.016
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. 2000. The protein data bank. Nucleic Acids Res. 28:235–242.10.1093/nar/28.1.235
- Case DA, Babin V, Berryman VJT, Betz RM, Cai Q, Cerutti DS, Cheatham TE, Darden TA, Duke RE, Gohlke H, et al. 2014. Amber 14. San Francisco: University of California.
- Kim KBWR, Kim MJ, Ahn DH. 2014. Lipase inhibitory activity of chlorophyll a, isofucosterol and saringosterol isolated from chloroform fraction of Sargassum thunbergii. Nat Prod Res. 28:1310–1312.10.1080/14786419.2014.900769
- Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN. 2014. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 63:1345–1354.10.1016/j.jacc.2014.01.022
- Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR, Powell C, Vedantam S, Buchkovich ML, Yang J. 2015. Genetic studies of body mass index yield new insights for obesity biology. Nature. 518:197–206.10.1038/nature14177
- Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. 2015. ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Computation. 11:3696–3713.10.1021/acs.jctc.5b00255
- Masmoudi-Allouche F, Touati S, Mnafgui K, Gharsallah N, El Feki A, Allouche N. 2016. Phytochemical profile, antioxidant, antibacterial, antidiabetic and anti-obesity activities of fruits and pits from date palm (Phoenix dactylifera L.) grown in south of Tunisia. J Pharmacogn Phytochem. 5:15–22.
- Mukherjee A, Sengupta S. 2013. Indian medicinal plants known to contain intestinal glucosidase inhibitors also inhibit pancreatic lipase activity–An ideal situation for obesity control by herbal drugs. IJBT. 12:32–39.
- Mukherjee A, Mukherjee S, Biswas J, Roy M. 2015. Phytochemicals in obesity control. Int J Curr Microbiol App Sci. 4:558–567.
- Nakamura K, Fuster JJ, Walsh K. 2014. Adipokines: a link between obesity and cardiovascular disease. Int J Cardiol. 63:250–259.
- Roe DR, Cheatham TE III. 2013. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation. 9:3084–3095.10.1021/ct400341p
- Roy U, Luck LA. 2007. Molecular modeling of estrogen receptor using molecular operating environment. Biochem Mol Biol Edu. 35:238–243.10.1002/(ISSN)1539-3429
- Seidell JC. 2000. Obesity, insulin resistance and diabetes–A worldwide epidemic. Br J Nutr. 83:S5–S8.
- Sukhdev S, Singh K. 2013. Therapeutic role of phytomedicines on obesity: importance of herbal pancreatic lipase inhibitors. Int Res J Med Sci. 1:15–26.
- Vaněčková I, Maletínská L, Behuliak M, Nagelová V, Zicha J, Kuneš J. 2014. Obesity-related hypertension: possible pathophysiological mechanisms. J Endocrinol. 223:R63–R78.10.1530/JOE-14-0368
- Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH. 2009. PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res. 37:W623–W633.10.1093/nar/gkp456